• Revenue up 30.7% to $48.2 million, driven by successful acquisitions and organic growth
• EBITDA up 60.1% to $8.3 million, with EBITDA margins expanding 310 bps to 17.1%
• NPAT up 61.7% to $4.7 million, with EPS increasing to 1.283 cents

Austco Healthcare Limited has reported a strong set of results for the first half of the 2026 financial year, with record revenue, EBITDA and net profit after tax. Revenue from customers increased 30.7% to $48.2 million, underpinned by the successful acquisitions made over the past few years and their integration, as well as organic growth in Australia/New Zealand and North America. Gross margins improved to 52.2%, up from 51.1% in the prior comparative period, despite the inclusion of the lower-margin G&S Technologies business. EBITDA grew 60.1% to $8.3 million, with EBITDA margins expanding 310 basis points to 17.1%, demonstrating the benefits of scale, disciplined cost control, and the increasing contribution from higher-margin acquired businesses. Net profit after tax increased 61.7% to $4.7 million, with basic earnings per share rising to 1.283 cents. The company's unfilled contracted revenue book remains healthy at $47.2 million, with software and SMA revenues comprising 18.5% of this. Austco Healthcare is in a strong financial position, with $15.2 million in cash and no debt.

Austco Healthcare has not provided any high-importance, price-sensitive forward-looking financial guidance in this announcement.